Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Morning Bell 27 January

Paulina Peters
January 27, 2021

Weekly Wrap 22 January

Jessica Amir
January 22, 2021

Morning Bell 22 January

Jessica Amir
January 22, 2021

Morning Bell 21 January

Jessica Amir
January 21, 2021

Morning Bell 20 January

Jessica Amir
January 20, 2021

Morning Bell 19 January

Jessica Amir
January 19, 2021

Morning Bell 18 January

Jessica Amir
January 18, 2021

Weekly Wrap 15 January

Jessica Amir
January 15, 2021

Morning Bell 15 January

Jessica Amir
January 15, 2021

Morning Bell 14 January

Jessica Amir
January 14, 2021

Morning Bell 13 January

Jessica Amir
January 13, 2021